Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
2009 NOV 29 ... function is now identified in mice, involving the impairment of cyclic-AMP- and protein-kinase-A-dependent forms of synaptic plasticity, or readiness for cognitive ... hallmark of learning.Researchers then treated the mice with PDE inhibitors, which rescued the sleep deprivation-induced deficits in cAMP signaling, synaptic ...
2009 NOV 23 ... "The kinase TAK1, a mitogen-activated protein kinase kinase kinase (MAP3K),has been widely accepted ... were transiently phosphorylated in response to TNF-alpha. Experiments using chemical inhibitors and small interfering RNA demonstrated that TNF-alpha-mediated phosphorylation of ...
2009 NOV 23 ... modifications in gamma-aminobutyric acid system via glutamate decarboxylase 67, protein kinase C beta and the receptor for activated C-kinase 1 (Rack1). Some studies indicate the ... but may improve when these are augmented with selective serotonin reuptake inhibitors (SSRIs). The molecular mechanisms underlying the augmentation are unclear," scientists ...
2009 NOV 23 ... permeability. In contrast to VEGF stimulation, Ang-1 causes a marked protein kinase C (PKC)-dependent increase in phosphorylation of eNOS on the inhibitory Thr(497). ... in phosphorylation of eNOS on the inhibitory Thr(497). Furthermore, using pharmacologic inhibitors, overexpression studies, and small interfering RNA-mediated gene silencing, we ...
2009 NOV 23 ... complex that processes many cell surface receptors including the EphB2 tyrosine kinase receptors (Litterst, C., Georgakopoulos, A., Shioi, J., Ghersi, E., Wisniewski, T., ... This phosphorylation occurs in the absence of Src kinases and is resistant to Src inhibitors revealing a novel pathway of NMDAR tyrosine phosphorylation independent of Src activity. ...
2009 NOV 23 ... production was shown to be dependent on the nuclear factor-kappaB and c-Jun N-terminal kinase signaling pathways. Triclosan inhibited c-Jun N-terminal kinase phosphorylation and ... assessed through western blotting and immunofluorescence using several cell-signaling inhibitors. Tumor necrosis factor-alpha was found to be a strong stimulus for urokinase production ...
2009 NOV 23 ... have previously reported that phosphorylation of IGFBP-3 (S156) by DNA-dependent protein kinase enhances its nuclear accumulation and is essential for its ability to interact with ... apoptosis in cultured prostate cancer cells." "Using specific chemical inhibitors and small interfering RNA, we demonstrate that preventing casein kinase 2 (CK2) ...
2009 NOV 23 ... as well as the mechanisms involved. iNOS levels and extracellular signal-regulated kinase (ERK) 1/2 activity were determined by western blotting. Nuclear factor (NF)-kappa B ... triggered a biphasic ERK 1/2 activation. By using the respective ERK 1/2 and NF-kappa B inhibitors, PD98059 and pyrrolidine dithiocarbamate, we established that iNOS induction by ...
2009 NOV 23 ... S100A4-neutralizing antibodies, as well as EGFR- and ErbB2 receptor-specific tyrosine kinase inhibitors, blocked these effects," wrote J. Klingelhofer and colleagues. The ...
2009 NOV 23 ... growing concern for resistance to imatinib and to subsequent second generation tyrosine kinase inhibitors (dasatinib and nilotinib) due to the T315I mutation. With no currently approved ...
2009 NOV 23 ... recently, cAMP was generally thought to potentiate insulin secretion through protein kinase A (PKA) phosphorylation of proteins associated with the secretory process. However, it ... Recently, glucagon-like peptide-1 (GLP-1) analogues and dipeptidyl peptidase-IV (DPP-IV) inhibitors have been developed as new antidiabetic drugs. These drugs all act through cAMP ...
2009 NOV 23 ... new data in the report 'Galectin-1 stimulates monocyte chemotaxis via the p44/42 MAP kinase pathway and a pertussis toxin-sensitive pathway.' According to a study from Falmer, the ... Furthermore, galectin-1-mediated monocyte migration was significantly inhibited by MEK inhibitors in a rapid, time-dependent manner suggesting that MAP kinase pathways are involved in ...
2009 NOV 23 ... of estradiol. Estradiol alone had no effects on GSH. Dibromo-cAMP mimicked and protein kinase A (PKA) inhibitors prevented FSH stimulation of GCL subunit protein levels. In cultured ...
2009 NOV 24 ... in Matrigel implants. Furthermore, two small molecule inhibitors of the PDGFR tyrosine kinase (i.e., imatinib and dasatinib) exerted negative effects on fSMC and mSMC growth in ex ...
2009 NOV 23 ... investigated the potential involvement of several signaling pathways, including protein kinase A (PKA), phosphatidylinositol 3 kinase (PIK3), mitogen-activated protein kinase 3/1 ... AR induced by inner perivitelline layer (IPVL) and Ca2+ was then examined using specific inhibitors and phosphorylation status measurements. The effects of the specific inhibitors on ...
2009 NOV 23 ... membrane and Thr34-DARPP-32 phosphorylation in MCF-7 cells. In agreement, both protein kinase A (PKA) inhibitors and siRNA-mediated knockdown of Frizzled-3 receptor or G alpha(s) ...
2009 NOV 23 ... Non-Small Cell Lung Cancer, Non-Small Cell Lung Carcinoma, Oncology, Paronychia, Protein Kinase Inhibitor, Pulmonology, Respiratory Infection, Seborrheic Dermatitis, Solid Cancers, ... According to a study from the United States, "Epidermal growth factor receptor inhibitors (EGFRIs) are new anticancer agents that act by inhibiting EGFR signaling transduction ...
2009 NOV 26 ... factor 2 (Nrf2) was stimulated by the compound and attenuated by phosphatidylinositol 3-kinase inhibitors such as LY294002 and wortmannin," wrote J.Y. Seo and colleagues, Kyungpook National ...
2009 NOV 23 ... blockers. Our aim was to investigate the mechanism of the vasorelaxant effects of Rho-kinase inhibitors (Y-27632 and fasudil) on the human RA," researchers in Sivas, Turkey report. ...
